{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:41:32Z","timestamp":1764603692870,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biochi.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:49:36Z","timestamp":1597391376000},"page":"50-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?"],"prefix":"10.1016","volume":"177","author":[{"given":"Razieh","family":"Dowran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Fazel","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Habtemariam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Shahmohamadnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosmin Andrei","family":"Cismaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeleh","family":"Sahebnasagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5114\/aoms.2020.94504","article-title":"Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2","volume":"16","author":"Nabavi","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.biochi.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biochi.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.biochi.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/ijms20163859","article-title":"Analysis of IFITM-IFITM interactions by a flow cytometry-based FRET assay","volume":"20","author":"Winkler","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3389\/fimmu.2018.01547","article-title":"Advancements in host-based interventions for influenza treatment","volume":"9","author":"Yip","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biochi.2020.08.006_bib7","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/v6093683","article-title":"IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms","volume":"6","author":"Wrensch","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biochi.2020.08.006_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biochi.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biochi.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biochi.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7182\/pit2013636","article-title":"Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products","volume":"23","author":"Jones","year":"2013","journal-title":"Prog. Transplant."},{"key":"10.1016\/j.biochi.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.07.017","article-title":"Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development","volume":"133","author":"Yin","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biochi.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1099\/jgv.0.000512","article-title":"Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in\u00a0vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans","volume":"97","author":"To","year":"2016","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.biochi.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.25562","article-title":"Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in\u00a0vitro and in\u00a0vivo","volume":"55","author":"Pan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2020.08.006_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1099\/vir.0.061911-0","article-title":"Interferon-\u03b2 and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays","volume":"95","author":"Hart","year":"2014","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.biochi.2020.08.006_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/1348-0421.12828","article-title":"Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2","author":"Kato","year":"2020","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.biochi.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2013.11.004","article-title":"IFITM proteins\u2014cellular inhibitors of viral entry","volume":"4","author":"Smith","year":"2014","journal-title":"Curr. Opin. Virol."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908420301917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908420301917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:15:31Z","timestamp":1759540531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908420301917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":18,"alternative-id":["S0300908420301917"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2020.08.006","relation":{},"ISSN":["0300-9084"],"issn-type":[{"type":"print","value":"0300-9084"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}